ISR Articles

  1. Industry Trends: CDMO Outsourcing 10/5/2022

    No single CDMO strategy or outsourcing model is appropriate for every project. Outsourcers can and should evaluate a strategy and partner(s) on a case-by-case basis.

  2. Small Molecule Drug Substance Outsourcing Drivers 10/4/2022

    ISR asked 57 respondents who outsource small molecule API which reason fits best with their company’s capacity for, and experience with, manufacturing small molecule drug substance. Read how the data shows the most common reason for outsourcing API manufacturing is a lack of capacity despite possessing in-house experience (42%).

     
  3. Biologic Drug Substance Outsourcing Drivers 10/4/2022

    ISR data from Q2 2022 shows the most common reason for outsourcing bioprocessing is a lack of capacity despite possessing in-house experience (41%).

  4. Understanding The Art And Science Of CRO Selection 9/19/2022

    This e-book examines the rationale behind how CROs are selected, why they are retained, and why sponsors opt for one provider or outsourcing model versus another.

  5. Top Therapeutic Areas For Highly Potent API 9/13/2022

    In Q1 of 2022, ISR asked 100 people who outsource highly potent drug substance what therapeutic areas their medications are designed to target. Discover the most common responses in this survey.

  6. Outsourced Bioprocessing By Respondent Location 9/13/2022

    Europeans report outsourcing slightly more bioprocessing to China, while American respondents send more work to Japan and other Asia-Pacific manufacturing facilities (excluding China and India).

  7. Industry Trends: Clinical Logistics Outsourcing 8/29/2022

    Understanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.

  8. Desired Integrated Clinical Logistics Activities 8/15/2022

    Learn why clinical labeling, clinical supply chain management, and storage and distribution of clinical trial materials received the most votes in a survey of 100 sponsors outsourcing clinical logistics.

  9. The Right Choice: Using Consultants For CDMO Selection 7/12/2022

    In Q2 2022, ISR asked 99 outsourcers whether the company they work for uses consultants to help guide their CDMO selection process. Read the results from ISR’s CDMO Outsourcing Models (3rd Edition) to gain insight into the use of consultants during CDMO selection.

  10. HPAPI Outsourcing Drivers 7/12/2022

    In Q1 2022, ISR surveyed 100 sponsors who outsource highly potent small molecule drug substance manufacturing and asked them why their companies use CDMOs for the work. Uncover the data of how respondents are augmenting the supply they make in-house.